Help us understand attention Learn more.

Help us understand attention Learn more

About the article

Most Recent

News & Articles

The Northwestern Anagram Test: Measuring Sentence Production in Primary Progressive Aphasia

Primary progressive aphasia (PPA) is a clinical dementia syndrome with early symptoms of language dysfunction. Postmortem findings are varied and include Alzheimer disease and frontotemporal lobar degeneration (FTLD), both tauopathies and TAR DNA binding protein (TDP-43) proteinopathies. Clinical-pathological correlations in PPA are complex but the presence in the clinical profile of agrammatism has a high association with tauopathy. Grammatical competence is difficult to assess in the clinical setting with available methods. This article describes the Northwestern Anagram Test (NAT), a new clinical measure of sentence production. A total of 16 patients with PPA and their controls assembled single printed words to create sentences describing pictures. Northwestern Anagram Test performance was significantly correlated with a measure of sentence production and with aphasia severity but not with measures of naming, single word comprehension, object recognition, or motor speech. The NAT can be used to assess syntax competence when patients cannot be tested with measures that require intact speech production.

Citation: Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK. The Northwestern Anagram Test: Measuring Sentence Production in Primary Progressive Aphasia. Am J Alzheimers Dis Other Demen. 2009 Aug 21. [Epub ahead of print]

full text article from publisher: 
Enter multiple addresses on separate lines
Source: 
American Journal of Alzheimer’s Disease & Other Dementias
Publication date: 
08/21/2009
Publisher: 
SAGE Publications

Search All News And Articles - Advanced

Return To Simple Search
gggg
Your comments for Dr.
Your name

Your email address will only be used for communicating with you regarding your correspondence. We will not sell or give away your information.

CAUTION: For your protection, we remind you that this is an unsecured email service, which is not intended for sending confidential or sensitive information. Please do not include your personal medical information in the content of the email. Please read our privacy policy for more details.